Plerixafor
Sold as Mozobil, Xaftrid, Pleditex, Zaplexet, Hemabo, Perifor, Plermob, Mobhem
1-[[4-(1,4,8,11-Tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane
Drag to rotate. Structure from PubChem CID 65015.
Background
Registration
- Applicants
- 3
- Registrations
- 8
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Sanofi-aventis South Africa (Pty) LtdCancelled | Mozobil | Not stated | 440546 | S4 | None |
| Aurogen South Africa (Pty) LtdCertificate held by Aurogen SA (Pty) Ltd | Xaftrid, Pleditex, Zaplexet | 24,0 mg | 550213, 550214.213, 550215.214 | S4 | PIPIL |
| Lebasi Pharmaceuticals (Pty) Ltd | Hemabo, Perifor, Plermob, Mobhem | 20 mg/ml | 590817, 590818.817, 590819.817, 590820.817 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Mozobil EACH VIAL CONTAINS PLERIXAFOR 24,0 mg | Not listed | 44054644/32.2/0546 | Cancelled | S4 | None |
| Xaftrid PLERIXAFOR | 24,0 mgSolution for injection | 55021355/32.2/0213Approved 18 October 2022 | Registered | S4 | PIPIL |
| Pleditex PLERIXAFOR | 24,0 mgSolution for injection | 550214.21355/32.2/0214.213Approved 18 October 2022 | Registered | S4 | PIPIL |
| Zaplexet PLERIXAFOR | 24,0 mgSolution for injection | 550215.21455/32.2/0215.214Approved 18 October 2022 | Registered | S4 | PIPIL |
| Hemabo 20 mg/ml EACH 1,0 ml SOLUTION CONTAINS: PLERIXAFOR 20,0 mg | 20 mg/ml | 59081759/32.16/0817 | Registered | S4 | None |
| Perifor 20 mg/ml EACH 1,0 ml SOLUTION CONTAINS: PLERIXAFOR 20,0 mg | 20 mg/ml | 590818.81759/32.16/0818.817 | Registered | S4 | None |
| Plermob 20 mg/ml EACH 1,0 ml SOLUTION CONTAINS: PLERIXAFOR 20,0 mg | 20 mg/ml | 590819.81759/32.16/0819.817 | Registered | S4 | None |
| Mobhem 20 mg/ml EACH 1,0 ml SOLUTION CONTAINS: PLERIXAFOR 20,0 mg | 20 mg/ml | 590820.81759/32.16/0820.817 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Plerixafor
S4: Plerixafor
Consolidated Schedules 06 July 2026, line 7588
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Xaftrid, Aurogen South Africa (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.